The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Coagulation Factors Market Research Report 2025
Synopsis
Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
The global Coagulation Factors market was valued at US$ 12770 million in 2023 and is anticipated to reach US$ 18800 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.
This report aims to provide a comprehensive presentation of the global market for Coagulation Factors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factors.
Report Scope
The Coagulation Factors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coagulation Factors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coagulation Factors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
Plasma-derived
Recombinant
Segment by Application
Pharmacy
Hospital
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coagulation Factors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coagulation Factors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
The global Coagulation Factors market was valued at US$ 12770 million in 2023 and is anticipated to reach US$ 18800 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.
This report aims to provide a comprehensive presentation of the global market for Coagulation Factors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factors.
Report Scope
The Coagulation Factors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coagulation Factors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coagulation Factors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
Plasma-derived
Recombinant
Segment by Application
Pharmacy
Hospital
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coagulation Factors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coagulation Factors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Coagulation Factors Market Overview
1.1 Product Overview and Scope of Coagulation Factors
1.2 Coagulation Factors Segment by Type
1.2.1 Global Coagulation Factors Market Value Comparison by Type (2024-2030)
1.2.2 Plasma-derived
1.2.3 Recombinant
1.3 Coagulation Factors Segment by Application
1.3.1 Global Coagulation Factors Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Coagulation Factors Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factors Revenue 2019-2030
1.4.2 Global Coagulation Factors Sales 2019-2030
1.4.3 Global Coagulation Factors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Coagulation Factors Market Competition by Manufacturers
2.1 Global Coagulation Factors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Coagulation Factors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Coagulation Factors Average Price by Manufacturers (2019-2024)
2.4 Global Coagulation Factors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coagulation Factors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Factors, Product Type & Application
2.7 Coagulation Factors Market Competitive Situation and Trends
2.7.1 Coagulation Factors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coagulation Factors Players Market Share by Revenue
2.7.3 Global Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coagulation Factors Retrospective Market Scenario by Region
3.1 Global Coagulation Factors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Coagulation Factors Global Coagulation Factors Sales by Region: 2019-2030
3.2.1 Global Coagulation Factors Sales by Region: 2019-2024
3.2.2 Global Coagulation Factors Sales by Region: 2025-2030
3.3 Global Coagulation Factors Global Coagulation Factors Revenue by Region: 2019-2030
3.3.1 Global Coagulation Factors Revenue by Region: 2019-2024
3.3.2 Global Coagulation Factors Revenue by Region: 2025-2030
3.4 North America Coagulation Factors Market Facts & Figures by Country
3.4.1 North America Coagulation Factors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Coagulation Factors Sales by Country (2019-2030)
3.4.3 North America Coagulation Factors Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Coagulation Factors Market Facts & Figures by Country
3.5.1 Europe Coagulation Factors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Coagulation Factors Sales by Country (2019-2030)
3.5.3 Europe Coagulation Factors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Factors Market Facts & Figures by Country
3.6.1 Asia Pacific Coagulation Factors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Coagulation Factors Sales by Country (2019-2030)
3.6.3 Asia Pacific Coagulation Factors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Coagulation Factors Market Facts & Figures by Country
3.7.1 Latin America Coagulation Factors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Coagulation Factors Sales by Country (2019-2030)
3.7.3 Latin America Coagulation Factors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Factors Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Factors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Coagulation Factors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Coagulation Factors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Factors Sales by Type (2019-2030)
4.1.1 Global Coagulation Factors Sales by Type (2019-2024)
4.1.2 Global Coagulation Factors Sales by Type (2025-2030)
4.1.3 Global Coagulation Factors Sales Market Share by Type (2019-2030)
4.2 Global Coagulation Factors Revenue by Type (2019-2030)
4.2.1 Global Coagulation Factors Revenue by Type (2019-2024)
4.2.2 Global Coagulation Factors Revenue by Type (2025-2030)
4.2.3 Global Coagulation Factors Revenue Market Share by Type (2019-2030)
4.3 Global Coagulation Factors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Coagulation Factors Sales by Application (2019-2030)
5.1.1 Global Coagulation Factors Sales by Application (2019-2024)
5.1.2 Global Coagulation Factors Sales by Application (2025-2030)
5.1.3 Global Coagulation Factors Sales Market Share by Application (2019-2030)
5.2 Global Coagulation Factors Revenue by Application (2019-2030)
5.2.1 Global Coagulation Factors Revenue by Application (2019-2024)
5.2.2 Global Coagulation Factors Revenue by Application (2025-2030)
5.2.3 Global Coagulation Factors Revenue Market Share by Application (2019-2030)
5.3 Global Coagulation Factors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Coagulation Factors Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Coagulation Factors Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Coagulation Factors Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Coagulation Factors Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Corporation Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Grifols Coagulation Factors Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biogen Coagulation Factors Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Coagulation Factors Product Portfolio
6.7.5 Octapharma Recent Developments/Updates
6.8 NovoNordisk
6.8.1 NovoNordisk Corporation Information
6.8.2 NovoNordisk Description and Business Overview
6.8.3 NovoNordisk Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 NovoNordisk Coagulation Factors Product Portfolio
6.8.5 NovoNordisk Recent Developments/Updates
6.9 Greencross
6.9.1 Greencross Corporation Information
6.9.2 Greencross Description and Business Overview
6.9.3 Greencross Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Greencross Coagulation Factors Product Portfolio
6.9.5 Greencross Recent Developments/Updates
6.10 Kedrion
6.10.1 Kedrion Corporation Information
6.10.2 Kedrion Description and Business Overview
6.10.3 Kedrion Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kedrion Coagulation Factors Product Portfolio
6.10.5 Kedrion Recent Developments/Updates
6.11 BPL
6.11.1 BPL Corporation Information
6.11.2 BPL Coagulation Factors Description and Business Overview
6.11.3 BPL Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BPL Coagulation Factors Product Portfolio
6.11.5 BPL Recent Developments/Updates
6.12 Hualan Bio
6.12.1 Hualan Bio Corporation Information
6.12.2 Hualan Bio Coagulation Factors Description and Business Overview
6.12.3 Hualan Bio Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hualan Bio Coagulation Factors Product Portfolio
6.12.5 Hualan Bio Recent Developments/Updates
6.13 RAAS
6.13.1 RAAS Corporation Information
6.13.2 RAAS Coagulation Factors Description and Business Overview
6.13.3 RAAS Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
6.13.4 RAAS Coagulation Factors Product Portfolio
6.13.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Factors Industry Chain Analysis
7.2 Coagulation Factors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Factors Production Mode & Process
7.4 Coagulation Factors Sales and Marketing
7.4.1 Coagulation Factors Sales Channels
7.4.2 Coagulation Factors Distributors
7.5 Coagulation Factors Customers
8 Coagulation Factors Market Dynamics
8.1 Coagulation Factors Industry Trends
8.2 Coagulation Factors Market Drivers
8.3 Coagulation Factors Market Challenges
8.4 Coagulation Factors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
